Delivery Order SPE2DB24D2100-SPE2DB24FBAKR

Award Date 3/18/24
Potential Completion Date 3/19/24
Potential Value $11K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of the VAXNEUVANCE 0.5 ML SYRINGE 0.5ML pharmaceutical product. The firm fixed price contract has a ceiling value of $10,256.38 and a period of performance through April 11, 2024. Amerisourcebergen Drug Corp is the prime contractor and has previously received numerous DLA...
The U.S. Department of Defense's Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of VAXNEUVANCE 0.5 ML SYRINGE 0.5ML. The $15,883.20 contract has a completion date of March 8, 2024 and was awarded on March 7, 2024. Amerisourcebergen Drug Corp, as a prime contractor, has been awarded numerous pharmaceutical and medical supply contracts by DLA to support military...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $12,792.00 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide VAXNEUVANCE 0.5 ML SYRINGE 0.5ML pharmaceutical products. This award is under an existing indefinite delivery contract (IDC) with a potential value of $999,999,999.00 and a performance period through December 31, 2025, which serves as the primary contract vehicle for AmerisourceBergen to deliver...
The U.S. government agency Defense Logistics Agency (DLA) Troop Support Medical awarded a delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide Vaxneuvance 0.5 ML syringe 0.5 ML. The firm fixed price contract has a ceiling value of $8,995.33 and a period of performance through April 15, 2024. AmerisourceBergen Drug Corp is the prime contractor, and this award is part of a larger indefinite delivery contract (IDC) with a potential...
This federal contract award, valued at $11,076.97, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The delivery order contract is for the supply of 0.5 mL syringes of the VAXNEUVANCE vaccine. The contract has a firm fixed price pricing type and an ultimate completion date of December 3, 2024. Amerisourcebergen, a for-profit organization, is registered in the System for Award Management (SAM.gov) and has established itself as...
This federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is for the delivery of VAXNEUVANCE 0.5 ML SYRINGE 0.5ML pharmaceutical products. The contract has a firm fixed price, with a potential value of $22,283.33, and a completion date of March 4, 2024. There is no set-aside designation for this award, which is a delivery order under Amerisourcebergen Drug Corp's existing indefinite delivery contract (IDC)...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $10,217.35 for the supply of 0.5 mL syringes of the vaccine VAXNEUVANCE. The contract has a firm fixed price and an ultimate completion date of January 10, 2024. This award is associated with AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
This federal contract award to Amerisourcebergen Drug Corp, through its Corporate Office division, is a delivery order valued at $3,363.42 for the supply of VAXNEUVANCE 0.5 ML SYRINGE 0.5ML. The award was made by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense, and does not have a set-aside designation. Amerisourcebergen Drug Corp is the prime contractor on a larger indefinite delivery contract (IDC) awarded by DLA, with a potential value of...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $13,218.89 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division to supply the VAXNEUVANCE 0.5 ML SYRINGE 0.5ML pharmaceutical product. This award is part of Amerisourcebergen's $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and...
This federal contract award, valued at $7,941.60, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the delivery of 0.5 mL syringes of the VAXNEUVANCE vaccine. This is a firm-fixed-price delivery order contract with a completion date of May 8, 2024. Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is a major supplier of pharmaceutical products and medical...
  • SPE2DB24D2100
    Indefinite Delivery Contract
  • SPE2DB24D2100-SPE2DB24FBAKR
    Delivery Order

This federal contract award, valued at $10,942.26, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of Vaxneuvance 0.5 ML syringes. The contract is a firm fixed price delivery order with a performance period through March 19, 2024. Amerisourcebergen Drug Corp is the prime contractor on this award, and no set-aside designation was used.

Amerisourcebergen Drug Corp is also the prime contractor on a larger indefinite delivery contract (IDC) awarded by DLA, valued at up to $999,999,999.00 through December 31, 2025. This IDC serves as the primary contract vehicle for Amerisourcebergen to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense.

Generated 6/17/24, 9:02 AM